TGTXTG THERAPEUTICS, INC.

Nasdaq tgtherapeutics.com


$ 25.19 $ -1.06 (-4.02 %)    

Wednesday, 18-Sep-2024 13:31:22 EDT
QQQ $ 474.45 $ -0.11 (-0.02 %)
DIA $ 417.61 $ 0.71 (0.17 %)
SPY $ 563.88 $ 0.02 (0 %)
TLT $ 100.39 $ 0.07 (0.07 %)
GLD $ 237.62 $ -0.57 (-0.24 %)
$ 25.08
$ 26.25
$ 25.20 x 200
$ 25.45 x 100
$ 25.12 - $ 26.25
$ 6.46 - $ 26.03
3,769,926
na
3.88B
$ 2.08
$ 40.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-06-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-10-2019 05-10-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-15-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-16-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-15-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-tg-therapeutics-maintains-49-price-target

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $49 price tar...

 whats-going-on-with-tg-therapeutics-stock-wednesday

TG Therapeutics announced it updated its data presentations to include details from the ULTIMATE I & II Phase 3 trials.

 whats-going-on-with-adma-biologics-stock-monday

ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.

 b-riley-securities-maintains-buy-on-tg-therapeutics-raises-price-target-to-34

B. Riley Securities analyst Mayank Mamtani maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target fr...

 goldman-sachs-maintains-neutral-on-tg-therapeutics-raises-price-target-to-20

Goldman Sachs analyst Corinne Jenkins maintains TG Therapeutics (NASDAQ:TGTX) with a Neutral and raises the price target fro...

 hc-wainwright--co-reiterates-buy-on-tg-therapeutics-maintains-49-price-target

HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $49 price tar...

 tg-therapeutics-q2-2024-gaap-eps-004-beats-005-estimate-sales-73466m-beat-65893m-estimate

TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION